<DOC>
	<DOCNO>NCT00931723</DOCNO>
	<brief_summary>The purpose study determine lithium 600-1800 mg/day effective add quetiapine fumarate extend release ( quetiapine XR SEROQUELÂ® XR ) 400-800 mg/day treat acute mania , compare placebo ( non-active capsule , like sugar pill , look like lithium ) .</brief_summary>
	<brief_title>Adult Bipolar Mania</brief_title>
	<detailed_description />
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<mesh_term>Lithium Carbonate</mesh_term>
	<criteria>Provision inform consent study procedure perform . The patient must document clinical diagnosis bipolar I disorder , include recent episode manic mixed , male female age 1865 year , inclusive . Patients may outpatients inpatient enrollment visit , patient must inpatients randomized remain inpatient discharge discretion investigator . The patient 8 mood episode past 12 month continuously hospitalize acute bipolar 3 week immediately participate study . The patient past diagnosis stroke medically document transient ischemic attack ( TIA ) history seizure disorder , except febrile convulsion . The patient must receive electroconvulsive treatment ( ECT ) within 90 day participate study doctor judgement pose current suicidal homicidal risk .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Acute Mania</keyword>
	<keyword>Mania , Adults</keyword>
	<keyword>Seroquel</keyword>
	<keyword>Acute Mania Adult Patients</keyword>
</DOC>